Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: A Study of Dotinurad Versus Allopurinol in Participants With Gout [Phase 3]

View source ↗

Summary

An ongoing Phase 3 clinical trial comparing dotinurad to allopurinol in patients with gout, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)
  • Dotinurad (dotinurad)

Snippet

Sponsor: Crystalys Therapeutics | Conditions: Gout | Phase 3 | Status: RECRUITING